key: cord-0907892-7qm8ignv
authors: Oladunni, Amos Abimbola; Haruna, Usman Abubakar; Ijafu, Lawrence Gregory; Lucero‐Prisno, Don Eliseo
title: Will people in conflict affected zones in Africa have access to COVID‐19 vaccine? A case of Nigeria
date: 2022-04-05
journal: Int J Health Plann Manage
DOI: 10.1002/hpm.3474
sha: a861106ef850253541a641d4e80aa6ecb9b19fa3
doc_id: 907892
cord_uid: 7qm8ignv

Vaccination is an important and cost‐effective disease prevention and control strategy. Over the years, milestone discoveries in vaccine research and development as well as vaccine delivery systems, have contributed to expanded immunisation coverage and reduction in morbidity and mortality associated with vaccine‐preventable diseases. While this outstanding development in vaccine delivery continues, there are considerable gaps in access to vaccines among populations living in fragile and conflict‐affected zones which appeared to be the fault line of limited vaccine coverage. Despite progress in coronavirus disease 2019 (COVID‐19) vaccine development, there are concerns about the feasibility of African countries affected by armed conflict and violence to effectively deliver COVID‐19 vaccines at the unprecedented level required to fight against the virus. In this article we discuss the feasibility of access to COVID‐19 vaccine among populations in conflict affected areas in Nigeria including methods that can be applied to reach and vaccinate populations in these settings.

The World Health Organisation (WHO) declared the novel coronavirus disease 2019 (COVID-19) a global health pandemic of International concern on the 11th of March 2020. 1 Since then, the new virus has continued to spread across the globe with more than 432 million cases and more than 5.9 million deaths as of 24 February 2022. 2 Its rapid dissemination has prompted biopharmaceutical industries to begin the development of novel therapeutic interventions and vaccines in order to fight against the virus. 3 There have been unfamiliar collaborations between giant pharmaceutical industries and governments in the race for vaccine development. 4 In February 2020, the WHO highlighted that a vaccine against SARS-CoV-2 is not expected to be available in less than 18 months. 5 Global efforts to develop and distribute COVID-19 vaccines have yielded accelerated development of multiple vaccines at an unprecedented level. The recent advancements in COVID-19 vaccine discovery have offered hope in the discovery of tools required to combat the new global threat. While the WHO has outlined general guidelines for vaccine prioritisation, many countries have set a distribution plan that prioritises at-risk populations including the elderly and health workers. 6 As of 13 February 2022%, 61.8% of the world population have been administered at least one dose of COVID-19 vaccine, with 10.6% in low and middle income countries. 7 There is already an overt gap in vaccination programs in different continents across the globe. In February 2021, the arrival of COVID- 19 Africa has shown to be one of the most skilful continents in the fight against disease outbreaks. The region has successfully implemented an expanded vaccine distributions and vaccinations in rural and remote communities. 9

While these experiences will provide valuable insight into COVID19 vaccine deployment in the continent, there are concerns on the feasibility of mass vaccination campaigns in fragile and conflict-affected zones. Conflict and violence exerts immediate impact on the determinants of health including access to essential health interventions. Inhabitants of conflicts affected areas are often faced with little or no access to lifesaving vaccines, making them more vulnerable to incidents and deaths due to vaccine-preventable diseases (VPDs). 10 The eruption of violence and conflict has been correlated with shortfalls in terms of immunisation outcomes leading to epidemics of VPDs in Africa. 11 Typical examples are widespread insurgencies in the Horn of Africa; armed insurgency in Somalia contributed to higher unimmunised or under-immunised populations resulting in widespread poliovirus infection following importation of the virus in the country, which spread to neighbouring countries (Ethiopia and Kenya) throughout 2013-2014. 12, 13 The emergence of COVID-19 has increased vulnerability and tension in the conflicted affected part of Nigeria. As of 24 February 2022, there are 254, 428 confirmed cases of COVID-19 with 3142 deaths across Nigeria. 14 Although 

Globally in 2015, two-third of the 20 million infants who are eligible for diphtheria, tetanus toxoids and pertussis (DTP) vaccines are from countries affected by armed conflicts. 16 Also, United Nations Children's Fund estimated in 2015 that six countries (Central African Republic, Equatorial Guinea, Somalia, Syrian Arab Republic, South Sudan, and Ukraine) that reported less than 50% coverage of the DTP vaccine were all experiencing conflicts or other humanitarian emergencies. 17 A similar pattern has been reported concerning the recent emergence of vaccine-deprived poliovirus infection outbreaks in seven conflict-affected settings in Africa including Nigeria. 18 Nigeria has experienced series of crisis (ethnic, religious and political violence) since independence, each leading to loss of lives and destruction of properties. The insecurity crisis in Nigeria include, among others, kidnapping, armed robbery, assassination, ritual killings in almost all parts of the country, and currently the activities of Boko Haram F I G U R E 1 Showing percentage of people who have received at least one dose of COVID19 vaccine in 40 African Countries (a non-state armed group that resists western education and modern science) in selected parts of the Northern region especially northeast. 19 In the past decades especially, there have been series of violent attacks linked to the activities of Boko Haram in the northern part of the country resulting in loss of lives and extensive damage to infrastructure, drawing further backwards the already slow development rate in the region. The frequent attacks have resulted in major loss of lives and extensive damage to infrastructure, causing devastating decline in health service delivery, decline in immunisation coverage and mass displacement of people from their homes.

Since 2009, the extended armed conflict in the North-Eastern states (Borno, Adamawa, and Yobe) in Nigeria has deprived almost 5.6 million people of access to health services. 20 The ongoing conflict has led to an escalation of attacks on healthcare which has resulted in the depletion of humanitarian spaces available for relief societies.

According to the WHO Surveillance System for Attacks on Healthcare, more than 40 attacks on healthcare have been 

People living in conflict-affected regions in Africa who have endured the double burden of conflict and COVID-19 deserve the right to access COVID-19 vaccines as do other vulnerable populations. It is crucial to consider and ensure the inclusion of this population in the COVID-19 national vaccination framework. The government in Nigeria must develop refined approaches in order to ensure safe and effective COVID-vaccine delivery to populations in conflict-affected areas. Based on available evidences and best practices, the following strategies can be adopted. 

Location intelligence helps immunisation programs to understand risk profiles of communities where they operate. The Government should evaluate the current security status in conflict affected regions as well as develop geographic intelligent assessments in areas affected by armed conflict. This will provide additional security to health workers based on current intelligence assessment and ensure effective planning and safe implementation of field COVID-19 vaccination activities. Application of geographic assessment tools can assist in development of maps for local testing and to quantify at-risk populations in hard-to-reach communities that have been prioritised to receive COVID-19 vaccines. This approach will help to predestinate COVID-19 vaccines at selected relatively safe locations with effective storage facilities before mapping redistribution routes for the vaccine delivery in security inaccessible areas. In addition, integration of vaccine distribution information database and geospatial data system will help inform vaccination activities across communities as well as track locations of populations that have been vaccinated.

Developing community engagement strategies is pivotal in ensuring an effective COVID-19 vaccine delivery in conflict and humanitarian emergency locations. The Volunteer Community Mobiliser programme, an initiative that recruited and trained local community women as vaccinators has been observed to improve participation in houseto-house routine immunisation programs in security-inaccessible communities in northern Nigeria. Engaging traditional and religious leaders in local communities, training of local residents as vaccinators and building community mobilisation networks will help improve access to COVID-19 vaccines. This will bring to light the key community engagement components that addresses issues associated with access to COVID-19 vaccines.

Vaccine delivery must be kept safe and at the right temperature requirement. Maintaining vaccine cold chain logistics is often difficult in areas affected by conflict and violence due to the break down and sometimes deliberates destruction of vital health services. There is need for the government to strengthen collaborations with local and international stakeholders in order to expand COVID-19 vaccine storage in conflict regions. This collaboration will foster instalment of solar-powered vaccine storage equipments at predestinated locations that are less vulnerable to attacks. This will allow mapping of redistribution routes for COVID-19 vaccine delivery to health facilities in security compromised areas. Delivery of potent COVID-19 vaccines to health facilities in security inaccessible sites can be conducted through the use of cooling vans and mobile cooling devices conditioned to specific storage temperature requirement for the vaccine storage.

People living in regions affected by conflict and violence in Africa often face little or no access to basic health services.

These populations are equally vulnerable to COVID-19 and have the right to be protected from the deadly infectious disease. It is important for the government in Nigeria to develop refined approaches towards inclusion and coverage of people in security compromised regions in COVID-19 vaccination framework. 

WHO Ramps up Preparedness for Novel Coronavirus in the African Region: WHO Regional Office for Africa

Accessed 15

Evolution of the COVID-19 vaccine development landscape

Here's Why the WHO Says a Coronavirus Vaccine Is 18 Months Away

COVID-19 Vaccine: Who Are Countries Prioritizing for First Doses

A Global Database of COVID-19 Vaccinations; 2022

Share of People Vaccinated against COVID-19

African Countries Have an Advantage in Rolling Out COVID-19 Vaccines

Approaches to vaccination among populations in areas of conflict

The impact of conflict on immunisation coverage in 16 countries

Polio outbreak investigation and response in Somalia

Forewarning of poliovirus outbreaks in the Horn of Africa: an assessment of acute flaccid paralysis surveillance and routine immunization systems in Kenya

COVID-19 Nigeria

Effect of armed conflict on vaccination: evidence from the Boko haram insurgency in north-eastern Nigeria

Two-third of Unimmunized Children Lives in Conflict-Affected Countries

Immunization: Current Status and Progress

Note from the field: circulating vaccine-deprived poliovirus outbreaks-five countries

Insecurity and National economic development implications for Nigeria's vision 20: 2020

How Community Engagement Prevents and Protects Health Care from Attacks in North-East Nigeria

Surveillance System for Attacks on Health Care (SSA)

Five Year Review Case-Base Surveillance Data

COVID-19 Vaccination Update in 36 States and the FCT

Transforming vaccines supply chains in Nigeria

Impact of engaging security personnel on access and polio immunization outcomes in security-inaccessible areas in Borno state

The authors declare that they have no competing interests.

Not applicable.

Amos Abimbola Oladunni and Usman Abubakar Harun developed the concept of the manuscript. Amos Abimbola Oladunni, Usman Abubakar Harun, Lawrence Gregory Ijafu and Don Eliseo Lucero-Prisno draughted and prepared the manuscript. DELP assisted with article interpretation and language edit. All authors read and approved the final manuscript.

No data are available.

https://orcid.org/0000-0002-6023-3725